May 10, 2019 4:15 pm EDT Abeona Therapeutics Reports First Quarter 2019 Financial Results and Business Highlights
May 8, 2019 8:30 am EDT Abeona Therapeutics Announces Presentation of EB-101 Data at Society for Investigative Dermatology Annual Meeting
May 1, 2019 8:00 am EDT Abeona Therapeutics Reports Preclinical Data Demonstrating Broad Therapeutic Potential of AIM™ Gene Therapy in Retinal Diseases at Association for Research in Vision and Ophthalmology Annual Meeting
Apr 30, 2019 8:00 am EDT Abeona Therapeutics to Report New Preclinical Data Demonstrating Therapeutic Potential of ABO-401 for Treatment of Cystic Fibrosis at American Society of Gene and Cell Therapy Annual Meeting
Apr 15, 2019 2:41 pm EDT Abeona Therapeutics to Present Data for ABO-401 in Cystic Fibrosis and Retinal Disorders at the American Society of Gene and Cell Therapy Annual Meeting
Apr 4, 2019 8:25 am EDT Abeona Therapeutics Receives FDA Fast Track Designation for ABO-101 for Treatment of Sanfilippo Syndrome Type B (MPS IIIB)
Mar 18, 2019 4:45 pm EDT Abeona Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
Feb 22, 2019 8:01 am EST Abeona Therapeutics Announces Participation in 8th Annual SVB Leerink Global Healthcare Conference
